College of Pharmacy News

The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) and seven regional partners and collaborators, including The University of Texas at Austin College of Pharmacy, will leverage $46 million from the National Institutes of Health (NIH) over the next five to seven years to translate scientific discoveries into therapeutic benefits for human health and well-being.

Andrea C. Gore, Ph.D., professor of pharmacology and toxicology and Vacek Chair in Pharmacology, recently earned an R35 RIVER grant award from the National Institute of Environmental Health Sciences (NIEHS) for her lab’s research on endocrine-disrupting chemicals (EDCs) and their effect on the brain. The NIEHS, which is one of the centers in the National Institutes of Health (NIH), awarded a total of $6,823,672 for eight years.

Kimberly J. Long, a Ph.D. candidate in the Dalby Lab in the Division of Chemical Biology and Medicinal Chemistry, was a first author of a recent research paper published in the Proceedings of the National Academy of Sciences (PNAS).

The University of Texas at Austin College of Pharmacy earns accolades for Best in Community Engagement, Best in Health Innovation, Best Project in Progress, Best in Visual and top 3 for People’s Choice Award at the Interprofessional Health Showcase 2023.

A new publication finds evidence that the repurposed drug apremilast suppressed alcohol consumption in people who drink excessively. The research is coauthored by Research Assistant Professor Regina Mangieri, Ph.D. in the Division of Pharmacology and Toxicology and Heather Aziz, MS, RLATg who works in the Mangieri Lab.

Division Head and Professor of Pharmacology & Toxicology Karen Vasquez, Ph.D. published in the latest issues of Nature Reviews Genetics regarding repetitive elements in the human genome. Once considered "junk DNA," they are now known to adopt more than a dozen alternative DNA structures. These dynamic conformations can act as functional genomic elements involved in DNA replication and transcription, chromatin organization and genome stability.

The Cancer Prevention and Research Institute of Texas (CPRIT) has released its grant research funding awards for the upcoming year. All three awarded research projects at The University of Texas at Austin involve College of Pharmacy faculty.

A paper from UT College of Pharmacy researchers was awarded the 2021 Outstanding Paper of the Year from the American College of Clinical Pharmacy (ACCP) Ambulatory Care Practice Research Network. The paper investigates the availability of buprenorphine and naloxone in Texas to treat opioid use disorder.

The Cancer Prevention and Research Institute of Texas (CPRIT) recently awarded grants to six faculty members at UT Austin, including the Division of Chemical Biology and Medicinal Chemistry's Kevin Dalby, Ph.D. for his Targeted Therapeutic Drug Discovery and Development Program.

UT Pharmacy and UT Health Science Center San Antonio Assistant Professor Grace C. Lee, Pharm.D., Ph.D. is the first author of a recently published study that unveiled a novel concept, “immunologic resilience,” to accurately predict which COVID-19 patients will advance to severe disease and which will not.